NASDAQ:AXLA - Axcella Health Stock Price, Forecast & News

Axcella Health trades on the NASDAQ under the ticker symbol "AXLA."

Axcella Health Inc (NASDAQ:AXLA) announced its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.71) by $0.04. View Axcella Health's Earnings History.

Axcella Health is scheduled to release their next quarterly earnings announcement on Tuesday, February 11th 2020. View Earnings Estimates for Axcella Health.

4 analysts have issued 1 year price targets for Axcella Health's shares. Their forecasts range from $20.00 to $25.00. On average, they expect Axcella Health's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 341.8% from the stock's current price. View Analyst Price Targets for Axcella Health.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axcella Health in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Axcella Health.

Media headlines about AXLA stock have been trending very negative on Saturday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Axcella Health earned a coverage optimism score of -3.8 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Axcella Health.

Axcella Health saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 122,800 shares, an increase of 61.2% from the December 15th total of 76,200 shares. Based on an average daily trading volume, of 58,100 shares, the short-interest ratio is presently 2.1 days. Currently, 1.5% of the company's stock are sold short. View Axcella Health's Current Options Chain.

Some companies that are related to Axcella Health include Aptose Biosciences (APTO), BioCryst Pharmaceuticals (BCRX), Cabaletta Bio (CABA), Gritstone Oncology (GRTS), PDL BioPharma (PDLI), Harpoon Therapeutics (HARP), Tcr2 Therapeutics (TCRR), Eiger Biopharmaceuticals (EIGR), Cellular Biomedicine Group (CBMG), Scholar Rock (SRRK), CASI Pharmaceuticals (CASI), Compugen (CGEN), Sutro Biopharma (STRO), ADMA Biologics (ADMA) and Jounce Therapeutics (JNCE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Axcella Health investors own include Triton International (TRTN), Main Street Capital (MAIN), Exelixis (EXEL), Achillion Pharmaceuticals (ACHN), Adobe (ADBE), Blackline (BL), Match Group (MTCH), Micron Technology (MU), Pilgrim's Pride (PPC) and Stamps.com (STMP).

(AXLA) raised $76 million in an initial public offering (IPO) on Thursday, May 9th 2019. The company issued 3,600,000 shares at a price of $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink acted as the underwriters for the IPO.

Shares of AXLA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AXLA stock can currently be purchased for approximately $4.98.

Axcella Health has a market capitalization of $115.09 million. View Additional Information About Axcella Health.

The official website for Axcella Health is http://www.axcellahealth.com/.

Axcella Health's mailing address is 840 MEMORIAL DRIVE, CAMBRIDGE MA, 02139. The company can be reached via phone at 857-320-2200.